Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Searches
(0)
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Online First
Supplements
NCCN Meeting Highlights
JNCCN In the News
COVID-19
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside
Search
Close
Advanced Search
Help
Volume 10 (2012): Issue 12 (Dec 2012)
in
Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Get eTOC Alerts
Get Ahead of Print Alerts
Citation Alert
NCCN News
Pages: xxviii–xxix
Oncology Research Program
Pages: xxxiii
Measuring Hope: Patient Expectations of Chemotherapy for Advanced Cancer
By:
Harold J. Burstein
Pages: 1459–1460
Accountable Care Organizations Are No Longer Unicorns, But They Are Still Zebras!
By:
Rita Potter
Pages: 1462–1463
Cancer Survivorship: We’ve Only Just Begun
By:
Mary S. McCabe
Pages: 1468–1470
Neoadjuvant Imatinib for Borderline Resectable GIST
By:
M. Zach Koontz
,
Brendan M. Visser
and
Pamela L. Kunz
Pages: 1477–1482
Non-Hodgkin’s Lymphomas, Version 3.2012
By:
Andrew D. Zelenetz
,
William G. Wierda
,
Jeremy S. Abramson
,
Ranjana H. Advani
,
C. Babis Andreadis
,
Nancy Bartlett
,
Naresh Bellam
,
John C. Byrd
,
Myron S. Czuczman
,
Luis Fayad
,
Martha J. Glenn
,
Jon P. Gockerman
,
Leo I. Gordon
,
Nancy Lee Harris
,
Richard T. Hoppe
,
Steven M. Horwitz
,
Christopher R. Kelsey
,
Youn H. Kim
,
Susan Krivacic
,
Ann S. LaCasce
,
Auayporn Nademanee
,
Pierluigi Porcu
,
Oliver Press
,
Barbara Pro
,
Nishitha Reddy
,
Lubomir Sokol
,
Lode Swinnen
,
Christina Tsien
,
Julie M. Vose
,
Joachim Yahalom
,
Nadeem Zafar
,
Maoko Naganuma
and
Mary A. Dwyer
Pages: 1487–1498
Strategies for Optimizing the Clinical Impact of Immunotherapeutic Agents Such as Sipuleucel-T in Prostate Cancer
By:
Ravi A. Madan
,
Thomas Schwaab
and
James L. Gulley
Pages: 1505–1512
Stereotactic Ablative Radiotherapy for Non–Small Cell Lung Cancer: Rationale and Outcomes
By:
Puneeth Iyengar
and
Robert D. Timmerman
Pages: 1514–1520
Rectal Cancer
By:
Al B. Benson III
,
Tanios Bekaii-Saab
,
Emily Chan
,
Yi-Jen Chen
,
Michael A. Choti
,
Harry S. Cooper
,
Paul F. Engstrom
,
Peter C. Enzinger
,
Marwan G. Fakih
,
Charles S. Fuchs
,
Jean L. Grem
,
Steven Hunt
,
Lucille A. Leong
,
Edward Lin
,
Michael G. Martin
,
Kilian Salerno May
,
Mary F. Mulcahy
,
Kate Murphy
,
Eric Rohren
,
David P. Ryan
,
Leonard Saltz
,
Sunil Sharma
,
David Shibata
,
John M. Skibber
,
William Small Jr
,
Constantinos T. Sofocleous
,
Alan P. Venook
,
Christopher G. Willett
,
Deborah A. Freedman-Cass
and
Kristina M. Gregory
Pages: 1528–1564
Controversies in Radiation for Upper Rectal Cancers
By:
Emily Chan
,
Paul E. Wise
and
A. Bapsi Chakravarthy
Pages: 1567–1572
Multidisciplinary Management of Early-Stage Rectal Cancer
By:
John G. Phillips
,
Theodore S. Hong
and
David P. Ryan
Pages: 1577–1585
Surveillance for Esophageal Cancer: Does it Make Sense?
By:
Mariela A. Blum Murphy
,
Takashi Taketa
,
Kazuki Sudo
,
Jeffrey H. Lee
and
Jaffer A. Ajani
Pages: 1590–1592
Collapse
Expand
Search
Issue
Journal
[3.230.1.126]
3.230.1.126
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
